Vector Surgical
Private Company
Funding information not available
Overview
Vector Surgical is a commercial-stage medical device company focused on improving surgical oncology outcomes through its Tissue Orientation System. Its flagship products, MarginMarker and CorrectClips, are designed to standardize and secure the marking of excised tissue margins, thereby reducing re-excision rates and improving communication between the surgical team and pathologists. The company has established a product portfolio that addresses clinical needs in breast, head & neck, pancreatic, cutaneous, and soft tissue sarcoma surgeries. It operates a direct commercial model, targeting hospitals and surgeons with its devices and supporting evidence from physician testimonials and clinical research.
Technology Platform
Integrated Tissue Orientation System comprising sterile marking inks (MarginMarker) and radiographic marker clips (CorrectClips) for secure, standardized intraoperative labeling of surgical specimen margins to guide pathology analysis.
Opportunities
Risk Factors
Competitive Landscape
Competes against simple, low-cost methods (sutures, non-sterile inks) and potentially other commercial tissue marking systems. Differentiation is based on system integration (ink + clips), clinical evidence of accuracy, and standardization. The market is fragmented, with Vector positioning itself as the premium, evidence-based standard.